Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

How many people might die, and why, under relaxed China COVID curbs

Published 12/20/2022, 03:29 AM
Updated 12/20/2022, 04:00 AM
© Reuters. Workers sort medicines at a logistics centre of China Resources Pharmaceutical Group Limited, amid the coronavirus disease (COVID-19) outbreaks in Beijing, China December 19, 2022. cnsphoto via REUTERS

SHANGHAI (Reuters) -China's abrupt end to its zero-COVID policy has raised concerns of widespread infections among a vulnerable, undervaccinated population with little natural immunity that would overload the health system and result in up to 2 million deaths, or more, various research groups are reporting.

New analyses by various modelling groups predict the reopening could result in as many as 2.1 million deaths.

As of Monday, China has officially reported 5,242 COVID-related deaths during the pandemic, a tiny fraction of its 1.4 billion population.

Here are some of the estimates:

MORE THAN 2 MILLION

Zhou Jiatong, head of the Center for Disease Control in southwestern Guangxi region, said last month in a paper published by the Shanghai Journal of Preventive Medicine that mainland China faces more than 2 million deaths if it loosened COVID curbs in the same way Hong Kong did this year.

Infections could rise to more than 233 million, his forecast showed.

1.55 MILLION

In May, scientists in China and the United States estimated that China risks just over 1.5 million COVID deaths if it drops its tough zero-COVID policy without any safeguards such as ramping up vaccination and access to treatments, according to research published in Nature Medicine.

They forecasted that peak demand on intensive care would be more than 15 times capacity, causing roughly 1.5 million deaths, based on worldwide data gathered about the variant's severity.

However, the researchers, the lead authors among whom were from Fudan University in China, said the death toll could be reduced sharply if there was a focus on vaccination.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

UP TO 2.1 MILLION

China could see 1.3 million to 2.1 million people die if it lifts its zero-COVID policy due to low vaccination and booster rates as well as a lack of hybrid immunity, British scientific information and analytics company Airfinity said in late November.

The company said it modelled its data on Hong Kong's BA.1 wave in February, which occurred after the city eased restrictions after two years.

MORE THAN 1 MILLION

The U.S.-based Institute of Health Metrics and Evaluation (IHME), part of the University of Washington, in an updated model said on Friday it expects more than 1 million deaths through 2023. The group expects cases to peak in April, when deaths will have reached 322,000.

About a third of China's population will have been infected by then, IHME Director Christopher Murray said.

A modelling team at the University of Hong Kong estimated simultaneous reopening of all provinces in December 2022 through January 2023 would result in 684 deaths per million, according to a paper released on Wednesday on the Medrxiv preprint server that has yet to undergo peer review.

Based on China's population of 1.41 billion, and without measures such as a mass vaccination booster campaign, that amounts to 964,400 deaths.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.